Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-519853-12-00Phase 3Authorised
Phase 3, randomised, double-blind trial in preeclampsia, intrauterine growth restriction (IUGR) and placental insufficiency comparing Pravastatin arm with Placebo arm (2 arms). Primary endpoint: Days of prolongation of pregnancy between inclusion and delivery. Planned start Jun 2025; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-519853-12-00.